"Oncology Associates at Mercy Medical Center provides high-quality hematology and oncology care for cancer patients close to home."

During the past decade, Mercy Regional Cancer Center at Mercy Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 50 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 57 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 83 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Regional Cancer Center at Mercy Medical Center" are "Breast Cancer" (23 trials), "Lung Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (7 trials), "Colorectal Cancer" (5 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Mercy Regional Cancer Center at Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Mercy Regional Cancer Center at Mercy Medical Center" are "Drug" (72 trials), "Biological" (28 trials), "Other" (25 trials), "Radiation" (13 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (19 trials), "carboplatin" (10 trials), "gemcitabine hydrochloride" (9 trials), "paclitaxel" (9 trials) and "bevacizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Regional Cancer Center at Mercy Medical Center" are 65 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Regional Cancer Center at Mercy Medical Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Mercy Regional Cancer Center at Mercy Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Regional Cancer Center at Mercy Medical Center, 4 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".